Literature DB >> 15194010

Isolation and characterization at cholinergic nicotinic receptors of a neurotoxin from the venom of the Acanthophis sp. Seram death adder.

Janith C Wickramaratna1, Bryan G Fry, Richard E Loiacono, Marie-Isabel Aguilar, Paul F Alewood, Wayne C Hodgson.   

Abstract

The present study describes the isolation of the first neurotoxin (acantoxin IVa) from Acanthophis sp. Seram death adder venom and an examination of its activity at nicotinic acetylcholine receptor (nAChR) subtypes. Acantoxin IVa (MW 6815; 0.1-1.0 microM) caused concentration-dependent inhibition of indirect twitches (0.1 Hz, 0.2 ms, supramaximal V) and inhibited contractile responses to exogenous nicotinic agonists in the chick biventer cervicis nerve-muscle, confirming that this toxin is a postsynaptic neurotoxin. Acantoxin IVa (1-10 nM) caused pseudo-irreversible antagonism at skeletal muscle nAChR with an estimated pA2 of 8.36+/-0.17. Acantoxin IVa was approximately two-fold less potent than the long-chain (Type II) neurotoxin, alpha-bungarotoxin. With a pKi value of 4.48, acantoxin IVa was approximately 25,000 times less potent than alpha-bungarotoxin at alpha7-type neuronal nAChR. However, in contrast to alpha-bungarotoxin, acantoxin IVa completely inhibited specific [3H]-methyllycaconitine (MLA) binding in rat hippocampus homogenate. Acantoxin IVa had no activity at ganglionic nAChR, alpha4beta2 subtype neuronal nAChR or cytisine-resistant [3H]-epibatidine binding sites. While long-chain neurotoxin resistant [3H]-MLA binding in hippocampus homogenate requires further investigation, we have shown that a short-chain (Type I) neurotoxin is capable of fully inhibiting specific [3H]-MLA binding.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194010     DOI: 10.1016/j.bcp.2004.03.033

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  5 in total

1.  Young and older good learners have higher levels of brain nicotinic receptor binding.

Authors:  Diana S Woodruff-Pak; Melissa A Lehr; Jian-Guo Li; Lee-Yuan Liu-Chen
Journal:  Neurobiol Aging       Date:  2008-10-23       Impact factor: 4.673

2.  Differential evolution and neofunctionalization of snake venom metalloprotease domains.

Authors:  Andreas Brust; Kartik Sunagar; Eivind A B Undheim; Irina Vetter; Daryl C Yang; Dary C Yang; Nicholas R Casewell; Timothy N W Jackson; Ivan Koludarov; Paul F Alewood; Wayne C Hodgson; Richard J Lewis; Glenn F King; Agostinho Antunes; Iwan Hendrikx; Bryan G Fry
Journal:  Mol Cell Proteomics       Date:  2012-12-12       Impact factor: 5.911

3.  Death adder envenoming causes neurotoxicity not reversed by antivenom--Australian Snakebite Project (ASP-16).

Authors:  Christopher I Johnston; Margaret A O'Leary; Simon G A Brown; Bart J Currie; Lambros Halkidis; Richard Whitaker; Benjamin Close; Geoffrey K Isbister
Journal:  PLoS Negl Trop Dis       Date:  2012-09-27

4.  Isolation and Pharmacological Characterization of α-Elapitoxin-Oh3a, a Long-Chain Post-Synaptic Neurotoxin From King Cobra (Ophiophagus hannah) Venom.

Authors:  Tam M Huynh; Anjana Silva; Geoffrey K Isbister; Wayne C Hodgson
Journal:  Front Pharmacol       Date:  2022-03-07       Impact factor: 5.810

5.  Isolation and Pharmacological Characterization of α-Elapitoxin-Ot1a, a Short-Chain Postsynaptic Neurotoxin from the Venom of the Western Desert Taipan, Oxyuranus temporalis.

Authors:  Carmel M Barber; Muhamad Rusdi Ahmad Rusmili; Wayne C Hodgson
Journal:  Toxins (Basel)       Date:  2016-02-29       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.